Overview
The Japan AI Agent market was valued at $250 million in 2024 and is projected to reach $2.43 billion by 2030, with a compound annual growth rate (CAGR) of 46.3%. AI innovation in sectors such as robotics, manufacturing, healthcare, and finance drives market growth. The government has launched a five-year AI support plan worth ¥1 trillion (approximately $6.34 billion), marking a new phase in the national AI strategy.
Market Information
| Dimension | Details |
|---|
| 2024 Market Size | $250 million |
| 2030 Projected Size | $2.43 billion |
| CAGR | 46.3% (2025-2030) |
| Core Drivers | Manufacturing, Healthcare, Finance, Retail |
| Largest Technology Segment | Machine Learning (highest revenue in 2025) |
| Fastest Growing Technology | Deep Learning |
Government AI Strategy
First National AI Basic Plan (December 2025)
- The Japanese government establishes a new AI company through public-private collaboration.
- Approximately 100 engineers from SoftBank and Preferred Networks.
- Five-year public support of about ¥1 trillion ($6.34 billion).
- Expected to commence in FY2026.
Strategic Goals
- Develop large-scale domestic foundational models.
- Promote AI applications across various industries.
- Establish an AI talent cultivation system.
Key Companies and Projects
Japanese Tech Giants
| Company | AI Initiatives | Features |
|---|
| SoftBank | Vision Fund investments, LLM development | Large-scale investments in AI startups |
| Hitachi | AI + logistics optimization | Industrial AI applications |
| NEC | AI security, biometrics | Enterprise-level AI solutions |
| Fujitsu | AI platform services | Supercomputers + AI |
AI Startups
| Company | Valuation | Core Business |
|---|
| Sakana AI | $2.65 billion | Domestic large models |
| Preferred Networks | Unicorn | Industrial AI, robotics |
| EdgeCortix | - | Edge AI chips |
Pharmaceutical AI Collaboration
- SoftBank, SB Intuitions, and Chugai Pharmaceutical signed a memorandum of cooperation in January 2025.
- Research on generative AI applications in clinical development.
- Develop AI agents and large language models specifically for the pharmaceutical industry.
Edge AI Development
- EdgeCortix received $21 million funding from NEDO.
- Develop energy-efficient edge AI chips.
- Plan to produce next-generation "NovaEdge" chips at TSMC's Kumamoto facility (2027).
Market Opportunities
- Government ¥1 trillion AI investment plan.
- Significant demand for digital transformation in manufacturing.
- Aging society drives demand for healthcare and service AI.
- Leading robotics technology provides hardware carriers for AI agents.
- Data sovereignty awareness promotes domestic AI development.
Market Challenges
- Severe shortage of AI talent.
- Slow pace of enterprise digital transformation.
- Limited resources for Japanese AI model development.
- Conservative corporate culture cautious about AI adoption.
- Pressure from international competition (US, Chinese AI companies).
Sources